Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
The First Affiliated Hospital with Nanjing Medical University
With
Guangzhou Burning Rock Bioengineering Ltd.
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Able to provide a written informed consent.
Female, at least 18 years old.
Pathologically confirmed breast cancer diagnosis or highly suspicious for breast cancer within 42 days prior to blood draw.
No prior cancer treatment before the blood draw.
Pathologically confirmed breast cancer diagnosis or highly suspicious of breast benign diseases within 90 days prior to blood draw.
No prior radical treatment before the blood draw.
You may not be if
During pregnancy or lactation.
Recipient of organ transplant or prior non-autologous (allogeneic) bone marrow or stem cell transplant.
Recipient of blood transfusion within 7 days prior to blood draw.
Recipient of anti-tumor drugs to treat non-cancer diseases prior to blood draw, such as rheumatic drugs (methotrexate, cyclophosphamide, or azathioprine), or endocrine drugs (tamoxifen).
Multiple primary tumors.
Clareo Health | PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale BREAST Cancers, PERCEIVE-BREAST
